MicroRNA profiling of paediatric AML with FLT-ITD or MLL-rearrangements: Expression signatures and in vitro modulation of miR-221-3p and miR-222-3p with BRD4/HATs inhibitors
Affiliations: Department of Paediatric Haematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, I-00146 Rome, Italy, Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, I-00161 Rome, Italy, Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210-1239, USA, Genomics Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210-1239, USA, Department of Biomedical Research, Urology Research Laboratory, University of Bern, CH-3008 Bern, Switzerland, Department of Women's and Children's Health (SDB), Hematology-Oncology Laboratory, University of Padova, I-35128 Padova, Italy
- Published online on: October 31, 2022 https://doi.org/10.3892/or.2022.8436
- Article Number: 221
Copyright: © Leoncini et al. This is an open access article distributed under the terms of Creative Commons Attribution License.